Yaushe allurar COVID-19 za su kasance a shirye don rarrabawa?
An riga an fara ƙaddamar da rigakafin COVID-19 na farko a cikin ƙasashe. Kafin a iya isar da allurar COVID-19:
Dole ne a tabbatar da allurar rigakafin lafiya da inganci a cikin manyan gwaje-gwaje na asibiti (lokaci III). Wasu 'yan takarar rigakafin COVID-19 sun kammala gwajin lokaci na III, kuma ana haɓaka wasu yuwuwar rigakafin.
Ana buƙatar sake dubawa masu zaman kansu na inganci da shaidar aminci ga kowane ɗan takarar rigakafin, gami da bita na tsari da amincewa a ƙasar da aka kera maganin, kafin WHO ta ɗauki ɗan takarar rigakafin don tantancewa. Wani ɓangare na wannan tsari kuma ya ƙunshi Kwamitin Ba da Shawarwari na Duniya kan Tsaron Alurar riga kafi.
Baya ga sake duba bayanan don dalilai na tsari, dole ne kuma a sake duba shaidar don manufar shawarwarin manufofin yadda ya kamata a yi amfani da alluran rigakafin.
Wani kwamitin kwararru na waje da WHO ta kira, wanda ake kira Kungiyar Ba da Shawarwari na Kwararru akan Immunization (SAGE), yayi nazarin sakamakon gwaje-gwajen asibiti, tare da shaida kan cutar, rukunin shekaru da abin ya shafa, abubuwan haɗari ga cututtuka, amfani da shirye-shirye, da sauran su. bayani. SAGE sannan ya ba da shawarar ko da yadda yakamata a yi amfani da allurar.
Jami'ai a kasashe daban-daban sun yanke shawarar ko za su amince da allurar rigakafin don amfanin kasa da kuma samar da manufofin yadda za a yi amfani da allurar a kasarsu bisa shawarar WHO.
Dole ne a samar da alluran rigakafin da yawa, wanda babban kalubale ne da ba a taba ganin irinsa ba - duk yayin da ake ci gaba da samar da dukkan wasu muhimman allurar ceton rai da aka riga aka fara amfani da su.
A matsayin mataki na ƙarshe, duk alluran rigakafin da aka amince da su za su buƙaci rarraba ta hanyar hadaddun tsarin dabaru, tare da ingantaccen sarrafa hannun jari da sarrafa zafin jiki.
WHO tana aiki tare da abokan tarayya a duk faɗin duniya don haɓaka kowane mataki na wannan tsari, tare da tabbatar da mafi girman ƙa'idodin aminci. Ana samun ƙarin bayani anan.
Shin akwai maganin rigakafi don COVID-19?
Ee, yanzu akwai alluran rigakafi da yawa da ake amfani da su. Shirin rigakafin farko na farko ya fara ne a farkon Disamba 2020 kuma daga ranar 15 ga Fabrairu 2021, an yi alluran rigakafi miliyan 175.3. Akalla alluran rigakafi 7 daban-daban ( dandamali 3) an gudanar da su.
WHO ta fitar da Jerin Abubuwan Amfani na Gaggawa (EULs) don maganin Pfizer COVID-19 (BNT162b2) a ranar 31 ga Disamba 2020. A ranar 15 ga Fabrairu 2021, WHO ta ba da EULs don nau'i biyu na rigakafin AstraZeneca/Oxford COVID-19, wanda Cibiyar Serum ta kera. na Indiya da SKBio. A ranar 12 ga Maris 2021, WHO ta ba da EUL don rigakafin COVID-19 Ad26.COV2.S, wanda Janssen (Johnson & Johnson ya haɓaka). WHO tana kan hanyar zuwa EUL sauran samfuran rigakafin har zuwa watan Yuni.
Samfuran da ci gaba a cikin bita na tsari ta WHO WHO ce ke bayarwa kuma ana sabunta su akai-akai. An ba da takardarNAN.
Da zarar an nuna cewa alluran rigakafin suna da aminci kuma masu inganci, dole ne hukumomin ƙasa su ba su izini, ƙera su zuwa daidaitattun ƙa'idodi, kuma a rarraba su. WHO tana aiki tare da abokan hulɗa a duk faɗin duniya don taimakawa daidaita mahimman matakai a cikin wannan tsari, gami da sauƙaƙe samun daidaitaccen damar samun amintacciyar rigakafin COVID-19 ga biliyoyin mutanen da za su buƙaci su. Ana samun ƙarin bayani game da ci gaban rigakafin COVID-19NAN.
Lokacin aikawa: Mayu-31-2021